|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 08013 | Phase II study with Gefitinib (sequentially) following Gemcitabine/Cisplatin as induction regimen for patients with stage IIIA N2 NSCLC |
| 40001 | Randomized study of pre-operative radio-chemotherapy versus surgery alone in thoracic oesophageal cancer deemed to be resectable |
| 05991 | A phase II study of chronomodulated preoperative infusional chemoradiation for biliary tract cancer |
| 10974 | LAMANOMA: Conservative local treatment versus mastectomy after induction chemotherapy in locally advanced breast cancer: a randomized phase III study. |
| 30001 | Radical Prostatectomy for Locally Advanced Prostate Cancer. A Feasibility Study. |
| 08981 | Surgical treatment of stage IIIB non-small cell lung cancer after induction chemo-radiotherapy. |
| 55963 | A randomized phase III study for the treatment of recurrent epithelial ovarian cancer: Chemotherapy alone versus chemotherapy followed by secondary cytoreductive surgery in patients with a treatment-free interval of more than 12 months-trial 55963 |
| 40971 | Total Mesorectal Excision (TME) with or without pre-operative radiotherapy in the treatment of primary rectal cancer. |
| 55962 | A randomized phase III trial for evaluation of usefullness of pelvic drains after radical hysterectomy and node dissection (RHND) |
| 15961 | An international field study of the reliability and validity of the EORTC QLQ-C30 and a disease specific questionnaire module (the EORTC QLQ-OES24) in assessing quality of life of patients with oesophageal cancer (15961/40973) |
| 24954 | Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemo-radiotherapy in resectable hypopharynx and larynx cancers (Jointly with the EORTC Radiotherapy Cooperative Group) |
| 22954 | Phase III study on larynx preservation comparing radiotherapy versus concomitant chemo-radiotherapy in resectable hypopharynx and larynx cancers (Joint study of the Radiotherapy Cooperative Group and the Head and Neck Cancer Cooperative Group). |
| 08961 | Phase II study of VIP (Etoposide, Ifosfamide and Cisplatin) in the treatment of invasive thymoma (In collaboration with ECOG, SWOG and CALGB) |
| 30947 | A randomized comparison of nephrectomy followed by Interferon Alpha 2-b (Intron-A) vs Interferon Alpha 2-b (Intron-A) alone in patients with advanced renal cell carcinoma. Phase III |
| 08941 | Randomized trial of surgery versus radiotherapy in patients with stage IIIa non-small cell lung cancer after a response to induction-chemotherapy. |
| 80931 | EORTC/MRC/SIOP/UKCCSG/CSG collaborative phase III randomized trial of chemotherapy with or without granulocyte colony-stimulating factor in operable osteosarcoma |
| 40911 | A phase III study of adjuvant regional and systemic chemotherapy in high risk resected colorectal cancers |
| 18902 | Study on the effect of elective lymph node dissection after wide local excision for head and neck melanomas (0.76 to 4.00 mm thick): A phase III randomized study (Jointly with the EORTC Melanoma Cooperative Group) |
| 40905 | Phase III trial of adjuvant chemotherapy with FAMTX in resectable gastric cancer |
| 30901 | A RANDOMIZED PHASE III TO COMPARE TUR AND YAG-LASER FOLLOWED BY INTRAVESICAL CHEMOPROPHYLAXIS WITH Epirubicin in SINGLE RECURRENT, MULTIPLE PRIMARY OR RECURRENT Ta-T1 TCC OF THE BLADDER |
| 30897 | Phase II study of Mitomycin C and intravesical immunotherapy with BCG-RIVM in recurrent superficial transitional cell carninoma of the bladder |
| 24891 | Is laryngeal preservation with induction chemotherapy safe in the treatment of hypopharyngeal squamous cell carcinoma ? A randomized phase III trial |
| 80871 | EORTC/MRC/SIOP/UKCCSG/CSG collaborative study to evaluate the efficacy of a chemotherapy protocol, consisting of a combination of platinum and Adriamycin in the treatment of spindle cell sarcoma of bone other than osteosarcoma. A non-randomized pilot study |
| 10873 | Phase II trial of breast conserving therapy in women with Paget's disease of the nipple |
| 40871 | A simple, large-scale randomized phase III trial on hepatic perfusion of 5-FU and heparin in resectable cancer of the colon and rectum |
| 55865 | Phase III study for the treatment of ovarian cancer FIGO stages IIB and C, III and IV |
| 24861 | Phase III Randomized Comparison of Chemotherapy with CDDP/5-FU Followed by Radiotherapy vs Radical Surgery with or without Radiotherapy in Patients with Nonmetastatic Squamous Cell Carcinoma of the Larynx |
| 08863 | CHEMOTHERAPY FOLLOWED BY SURGERY AND RADIOTHERAPY IN NSCLC PATIENTS WITH BIOPSY PROVEN N2 DISEASE. A PHASE II STUDY. |
| 80861 | EORTC/MRC/SIOP/UKCCSG collaborative randomized phase III study to compare and evaluate two protocols of chemotherapy in the treatment of operable osteosarcoma |
| 10854 | Phase III trial of perioperative adjuvant chemotherapy in Breast Cancer |
| 30853 | Phase III protocol for a randomized prospective study of the treatment of patients with metastatic prostatic cancer to compare the therapeutic effect of orchidectomy versus LHRH-analogue depot preparation supplemented by an antiandrogen |
| 26851 | Phase III trial comparing the effect of cisplatinum given during radiation therapy to radiation therapy alone in patients with supratentorial malignant brain gliomas. |
| 10850 | PHASE III TRIAL ON OPERABLE BREAST CANCER IN THE ELDERLY. TUMOR EXCISION PLUS Tamoxifen COMPARED WITH RADICAL MASTECTOMY |
| 10851 | PHASE III TRIAL ON OPERABLE BREAST CANCER IN THE ELDERLY: Tamoxifen ALONE COMPARED WITH MODIFIED RADICAL MASTECTOMY |
| 08845 | ADJUVANT SURGERY AFTER INDUCTION CHEMOTHERAPY IN LIMITED SMALL CELL LUNG CANCER A RANDOMIZED PROSPECTIVE STUDY. |
| 24844 | 5-FU/CDDP FOLLOWED BY SURGERY AND RADIOTHERAPY vs SURGERY AND RADIOTHERAPY IN ADVANCED SQUAMOUS CELL CARCINOMA OF LATERAL OROPHARYNX AND LATERAL POSTERIOR ORAL CAVITY (Phase III trial) |
| 18832 | Randomized phase III trial comparing surgery with or without prophylactic isolation perfusion for stage I high risk (> 1.5 mm thickness) malignant melanoma of the limbs (Jointly with WHO and NAPG) |
| 40812 | Clinical trial on adjuvant therapy of resectable colon cancer with 5-Fluorouracil administered by portal vein perfusion. |
| 40813 | Adjuvant chemotherapy in resectable gastric cancer. |
| 08031 | Phase II feasibility trial of induction chemotherapy followed by extrapleural pneumonectomy and postoperative radiotherapy in patients with malignant pleural mesothelioma |
| 22011 | Continuous fluorouracil plus mitomycin C versus mitomycin C plus Cisplatin as chemotherapy combination in combined radiochemotherapy for locally advanced anal cancer. A phase II-III study. |
| 40954 | Randomized phase III study of preoperative chemotherapy followed by surgery versus surgery alone in locally advanced gastric cancer (cT3 and cT4NxM0). |
| 40906 | Adjuvant intraoperative radiotherapy in gastric cancer. |
| 30881 | Phase III trial of the investigation of the potentially curative value of lymphadenectomy in conjunction with radical nephrectomy for non-metastatic renal cell carcinoma |
| 40983 | Pre-and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV versus Surgery alone in Resectable Liver Metastases from Colorectal Origin- Phase III Study |
| 22921 | Four arms phase III clinical trial for T3-T4 resectable rectal cancer comparing pre-operative pelvic irradiation to pre-operative irradiation combined with fluorouracil and Leucovorin with or without post-operative adjuvant chemotherapy |
| 22881 | Phase III study in the conservative management of breast carcinoma by tumorectomy and radiotherapy: assessment of the role of a booster dose of radiotherapy (Joint study of the EORTC Radiotherapy Cooperative Group and the EORTC Breast Cancer Cooperative Group) |
| 30847 | Phase II protocol to study management of stage I non-seminomatous testicular cancer with unilateral orchidectomy alone |
| 08012 | Pre-operative chemotherapy in resectable NSCLC. Randomised trial of surgical resection with or without pre-operative chemotherapy in patients with operable non small cell lung cancer (NSCLC) of any stage. |
| 55971 | Randomized Phase III study comparing upfront debulking surgery versus neo-adjuvant chemotherapy in patients with Stage IIIc or IV epithelial ovarian carcinoma. |
| 30955 | Phase III adjuvant trial:Interleukin-2, Interferon-alpha and 5-Fluorouracil for patients with high risk of relapse after surgical treatment for RCC |
| 62933 | Metastasectomy and chemotherapy for lung metastases from soft tissue sarcoma. A randomized phase III study (an Intergroup Study with the Scandinavian Sarcoma Group) |
| 30904 | A Prospective Randomized Ohase III study Comparing Radical Surgery to Elective Kidney Sparing Surgery for Low Stage Renal Cell Carcinoma |
| 30073 | Randomized Phase III trial comparing immediate versus deferred nephrectomy in patients with synchronous metastatic renal cell carcinoma. |
| 62063 | A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate. |
| 40054 | Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaplatin vs.capecitabine alone in locally advanced rectal cancer (PETACC-6). |
| 55994 | Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs. concomitant radiotherapy and chemotherapy in FIGO Ib2, IIa > 4 cm or IIb cervical cancer. |
| 10981 | After Mapping of the Axilla:Radiotherapy Or Surgery AMAROS |
| 40051 | Randomized phase II trial evaluating the feasibility and tolerance of the combination of FOLFOX with cetuximab and the combination of FOLFOX with cetuximab and bevacizumab as perioperative treatment in patients with resectable liver metastases from colorectal cancer (BOS). |
| 08051 | Randomized Phase II Study Of Pemetrexed And Cisplatin As Either Induction or Adjuvant Chemotherapy In Stage IB-II Non-Small Cell Lung Cancer (NSCLC) |
| 20871A | Phase III for the treatment of localized intermediate and high grade gastrointestinal tract non-Hodgkin's lymphoma - stage I - |
| 20871B | Phase III for the treatment of localized intermediate and high grade gastrointestinal tract non-Hodgkin's lymphoma - stage II - |